ANI Pharmaceuticals, Inc. (ANIP)
ANI Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Baudette, MN, US. The stock last traded at $74.14, down 0.52% on the session, giving a market capitalisation of $1.69B. On trailing twelve-month figures it carries a trailing P/E of 15.35, a net margin of 10.8%. Its beta of 0.46 implies it has historically moved less than the broad market.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals, Inc. is most often compared with the following Healthcare names: